Global DNA Sequencing Market 2021

January 2022 | 20 pages | ID: G6B49C9DBEC7EN
StrategyHelix Inc

Abstracts

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. The global dna sequencing market is set to increase by US$ 22,159 million from 2021 to 2027, representing a compound annual growth rate (CAGR) of 17.6% during the forecast period.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for dna sequencing. The global dna sequencing market is segmented on the basis of product, sequencing type, end user, and region. On the basis of product, the global dna sequencing market has been segmented into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. However, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2021 - 2027. By sequencing type, the global dna sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, others. Among these, the NGS segment was accounted for the highest revenue generator in 2020. Based on end user, the global dna sequencing market is categorized into hospitals & healthcare organizations, academics & research institutions, enterprises, others. In terms of geography, the global dna sequencing market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global dna sequencing market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific Inc., F. Hoffmann-La Roche AG, Illumina Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., BGI Group, QIAGEN N.V.

Report Scope
Product: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, others
End user: hospitals & healthcare organizations, academics & research institutions, enterprises, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global dna sequencing market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. DNA SEQUENCING MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

Sequencing services
Sequencing instruments
Sequencing consumables
Sequencing informatics

PART 4. MARKET BREAKDOWN BY SEQUENCING TYPE

Next generation sequencing (NGS)
Sanger sequencing
Others

PART 5. MARKET BREAKDOWN BY END USER

Hospitals & healthcare organizations
Academics & research institutions
Enterprises
Others

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Danaher Corporation
Eurofins Scientific, Inc.
F. Hoffmann-La Roche AG
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
BGI Group
QIAGEN N.V.
About StrategyHelix
Disclaimer